Context Therapeutics Reports First Quarter 2023 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2023 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.61 +0.02 (3.39%)
Previous Close $0.59    52 Week High
Open $0.61    52 Week Low
Day High $0.61    P/E N/A 
Day Low $0.60    EPS
Volume 62,825